Geert-Jan Mulder

Geert-Jan Mulder is on these Sector & Stage Rankings

Geert-Jan Mulder's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Citryll	Series BDec 2024$90M	$110M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures)), Isabelle de Cremoux (Seventure Partners)
Mariana Oncology	Series BSep 2023$180M	$250M
Co-investors: Dan Becker (Access Biotechnology), Kevin Bitterman (Atlas Venture), Josh Resnick
Complement Therapeutics	Series AApr 2023$79M SeedFeb 2022$6M	$85M
Co-investors: Dmitrij Hristodorov (Forbion), Max Klement (BGV (BioGeneration Ventures)), Anne Horgan (Cambridge Innovation Capital)
Prilenia	Series BNov 2021$43M Series AJun 2020$63M	$110M
AM Pharma	Series UnknownMar 2020$25M Series FJul 2019$130M Series CAug 2007$3M	$210M
Co-investors: Raphael Wisniewski (Andera Partners), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Exosome Diagnostics	Series CJul 2017$30M Series BJan 2016$16M Series BSep 2015$18M Series BMar 2014$27M Series AMay 2010$20M	$110M
Co-investors: Steven Soignet (Arcus Ventures), Marco Boorsma (Forbion)
Bluebird Bio	Series DJul 2012$60M Series CApr 2011$30M Series BMar 2010$35M	$130M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Tepper (Third Rock Ventures), Philip Reilly (Third Rock Ventures)
Promedior	Series DMar 2012$22M Series CMar 2010$12M	$48M
Co-investors: Amir Nashat (Polaris Partners)